TC BioPharm (Holdings) PLC (TCBP)
0.69
+0.04
(+6.34%)
USD |
NASDAQ |
Nov 15, 16:00
0.6258
-0.06
(-9.30%)
After-Hours: 18:31
TC BioPharm Free Cash Flow (Quarterly): -3.062M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.062M |
| June 30, 2023 | -4.757M |
| March 31, 2023 | -3.715M |
| Date | Value |
|---|---|
| December 31, 2021 | |
| September 30, 2021 | -4.309M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-4.757M
Minimum
Jun 2023
-3.062M
Maximum
Mar 2024
-3.961M
Average
-4.012M
Median
Free Cash Flow (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 46.64M |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -62.66M |
| NuCana PLC | -1.569M |
| Autolus Therapeutics PLC | -51.92M |